Migraine History, Nonsteroidal Anti-inflammatory Drug Use, and Risk of Postmenopausal Endometrial Cancer

Hormones and Cancer

Volumn 3, Issue 5-6, 2012, Pages 240-248

  Phipps, Amanda I ^a,b   Anderson, Garnet L ^a,b   Cochrane, Barbara B ^a,b   Li, Christopher I ^a,b   Wactawski Wende, Jean ^c   Ho, Gloria Y F ^d   O'Sullivan, Mary Jo ^e   Newcomb, Polly A ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PRESCRIPTION DRUG;

ARTICLE; BODY MASS; CANCER RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG USE; ENDOMETRIUM CANCER; FOLLOW UP; HUMAN; MEDICAL HISTORY; MIGRAINE; POSTMENOPAUSE; PRIORITY JOURNAL; STRUCTURED INTERVIEW;

EID: 84869088109     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-012-0117-7     Document Type: Article

References (40)

1. Campbell S, McQueen J, Minardi J, Whitehead MI (1978) The modifying effect of progestogen on the response of the post-menopausal endometrium to exogenous oestrogens. Postgrad Med J 54(Suppl 2): 59-64.
2. Modungo F, Ness RB, Chen C, Weiss NS (2005) Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev 14: 2840-2847.
3. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D (1995) Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 85: 304-313.
4. Kaaks R, Lukanova A, Kurzer MS (2002) Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11: 1531-1543.
5. Vainio H, Bianchini F (2002) Weight control and physical activity. IARC handbook for cancer prevention, vol 6. IARC, Lyon.
6. Zacur HA (2006) Hormonal changes throughout life in women. Headache 46(Suppl 2): S49-S54.
7. Martin VT, Lipton RB (2008) Epidemiology and biology of menstrual migraine. Headache 48(Suppl 3): S124-S130.
8. MacGregor EA (2009) Migraine headache in perimenopausal and menopausal women. Curr Pain Headache Rep 13: 399-403.
9. Mathes RW, Malone KE, Daling JR et al (2008) Migraine in postmenopausal women and the risk of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 17: 3116-3122.
10. Li CI, Mathes RW, Malone KE et al (2009) Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev 18: 2030-2034.
11. Li CI, Mathes RW, Bluhm EC et al (2010) Migraine history and breast cancer risk among postmenopausal women. J Clin Oncol 28: 1005-1010.
12. Gao J, Niwa K, Sun W et al (2004) Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells. Cancer Sci 95: 901-907.
13. Gates MA, Tworoger SS, Eliassen AH, Missmer SA, Hankinson SE (2010) Analgesic use and sex steroid hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 19: 1033-1041.
14. Takkouche B, Regueira-Mendez C, Etminan M (2008) Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis. J Natl Cancer Inst 100: 1439-1447.
15. Zhao YS, Zhu S, Li XW et al (2009) Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis. Breast Cancer Res Treat 117: 141-150.
16. Harris RE, Chlebowski RT, Jackson RD et al (2003) Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res 63: 6096-6101.
17. Moysich KB, Baker JA, Rodabaugh KJ, Villella JA (2005) Regular analgesic use and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 14: 2923-2928.
18. Viswanathan AN, Feskanich D, Schernhammer ES, Hankinson SE (2008) Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer. Cancer Res 68: 2507-2513.
19. Fortuny J, Sima C, Bayuga S et al (2009) Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiol Biomarkers Prev 18: 1448-1456.
20. Danforth KN, Gierach GL, Brinton LA et al (2009) Nonsteroidal anti-inflammatory drug use and endometrial cancer risk in the NIH-AARP Diet and Health Study. Cancer Prev Res (Phila) 2: 466-472.
21. Bodelon C, Doherty JA, Chen C, Rossing MA, Weiss NS (2009) Use of nonsteroidal antiinflammatory drugs and risk of endometrial cancer. Am J Epidemiol 170: 1512-1517.
22. Bosetti C, Bravi F, Talamini R, Montella M, Negri E, La Vecchia C (2010) Aspirin and risk of endometrial cancer: a case-control study from Italy. Eur J Cancer Prev 19: 401-403.
23. Prizment AE, Folsom AR, Anderson KE (2010) Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 19: 435-442.
24. The Women's Health Initiative Study Group (1998) Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 19: 61-109.
25. Hays J, Hunt JR, Hubbell FA et al (2003) The Women's Health Initiative recruitment methods and results. Ann Epidemiol 13: S18-S77.
26. Therneau TM, Grambsch PM (2000) Modeling survival data: extending the Cox model. Springer, New York.
27. MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A (2006) Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 67: 2154-2158.
28. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF (2002) Migraine in the United States: epidemiology and patterns of health care use. Neurology 58: 885-894, 28.
29. Schreinemachers DM, Everson RB (1994) Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5: 138-146.
30. Akhmedkhanov A, Toniolo P, Zeleniuch-Jacquotte A, Kato I, Koenig KL, Shore RE (2001) Aspirin and epithelial ovarian cancer. Prev Med 33: 682-687.
31. Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS (2005) Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 294: 914-923.
32. Peto R, Gray R, Collins R et al (1988) Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) 296: 313-316.
33. Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH (1993) Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 85: 1220-1224.
34. Baron JA, Cole BF, Sandler RS et al (2003) A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348: 891-899.
35. Cook NR, Lee IM, Gaziano JM et al (2005) Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 294: 47-55.
36. Rothwell PM, Wilson M, Elwin CE et al (2010) Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376: 1741-1750.
37. Lipton RB, Stewart WF, Celentano DD, Reed ML (1992) Undiagnosed migraine headaches. A comparison of symptom-based and reported physician diagnosis. Arch Intern Med 152: 1273-1278.
38. Lipton RB, Stewart WF (1993) Migraine in the United States: a review of epidemiology and health care use. Neurology 43: S6-S10.
39. Lipton RB, Stewart WF, Simon D (1998) Medical consultation for migraine: results from the American Migraine Study. Headache 38: 87-96.
40. Stewart WF, Wood C, Reed ML, Roy J, Lipton RB (2008) Cumulative lifetime migraine incidence in women and men. Cephalalgia 28: 1170-1178.